Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Metastatic Adenocarcinoma of the Pancreas × 130-nm albumin-bound paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Neoplasm Metastasis 1 Metastatic Adenocarcinoma of the Pancreas 1 Carcinoma 1

Interventions

irinotecan sucrosofate 1 Oxaliplatin 1 Leucovorin 1 Gemcitabine 1 Fluorouracil 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04083235 2026-03-09

NAPOLI 3

Ipsen

Phase 3 Completed

770 enrolled 13 charts 1 FDA

Gastrointestinal

Metastatic Adenocarcinoma of the Pancreas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡